Desarrollo de Negocios Internacionales para Laboratorios Argentinos, Brasileros, Europeos y Asiaticos.Establecimiento de Plataforma de Comercializacion en el Mercado Argentino y de Cono Sur para Laboratorios Argentinos y ExtranjerosIn LicensingContract Manufacturer Agreements hacia y desde ArgentinaComercializacion de Equipos MedicosElaboracion de Dossiers para Registro de Productos en Mercados Regionales

Main achievements:• Research of Contract Manufacturer and Development of Oncology Platform• Research of Distribution Agreement and Development of Biotech business platform • Research of Distribution Agreement and Development of Phlebology Business • Research and Distribution Agreement of Plasma Derivates business platform. • Research and Distribution Agreement of Woman Health Hormonals business.

Anesthesia - Injectables• Responsible for the Yemeni Minister of Health authorities Inspection and Approval of two plants in Sao Paulo.• Yemen Market Projected business first 2 years usd 6 millons.• Anesthesia API exports to Argentine Labs.

Responsible for the development of Biological Business in Guatemala and MENA markets . Sales for more usd 5 millons first 2 years (2012 and 2013) with only one Biologic Product. More Developments in process.

Main achievements:Exports structure Creation Initial research of Regional markets. Elaboration, presentation and implementation of International BusinessElaboration, presentation and implementation of DMF Library Plan Development of a distributors and agents network in countries of Latin America, Eastern Europe and Asia.

Responsible for the strategic development of Marpel Pharma Oncology Brand, and, with projected 3 years sales of around U$ 24 Million, organizing and managing a new platform of international distributors in more than 25 countries in 4 continents. Lab. IMA is the biggest South American Oncology Contract Manufacturing Company, adquired by Brazilia Giant Pharmaceutical Company Cristalia in 2012. Development of Oncology Business in Colombia

Main achievements:Exports structure Creation Initial research of Regional markets. Elaboration, presentation and implementation of International BusinessElaboration, presentation and implementation of DMF Library Plan Development of a distributors and agents network in 10 countries of America, Eastern Europe and Asia.

Main achievements:Creation of local structure (Marpel Pharma Argentina is part of the Group Marpel Pharma, a regional multinational company)Creation of a new exports platform, with 160 new registration processes in different markets.Regional Agreement with Shangai Pharmaceuticals (first chinese consortium of API’ ), and ACG (second world largest company of empty capsules) to develop South American Markets.Regional Agreement with Karnataka Antibiotics, Veterinary division – animals for production & poultry. Two years developing market plan: USD 4,5 million.Development of a distributors and agents network in 23 countries of America, Europe, Africa and Asia.API’s supplier of the principal pharmaceutical companies in Argentina

Camara Empresaria de Laboratorios Argentinos de Especialidades Medicinales

Responsible for the strategic development of Filaxis, a generic Oncology and Anti-Retroviral pharmaceutical company with annual sales of around U$ 20 Mio, organizing and managing a new platform of international distributors in more than 30 countries in 4 continents. Filaxis is a company with an Argentine industrial base, which was until 12/2002 owned by the Serono Group.Main achievements:Development of a distributors and agents network in 31 countries of America, Europe, Africa and Asia. (Annexes included)During my management, sales growth was more than 380% Resolution of prior contracts and business reconduction in new distributors.Creation of a new commercial platform, with 202 new registrations obtained. Corporative culture transformation of Filaxis from a local argentine company with sales only in Argentina and neighbouring countries into an International Oncology company. Growth in share of total company sales from 3% to 42%.Regional Agreement with Merck to develop and supply OncoBrand products for 12 Latin American countries. Approval of PAHO (Pan American Health Organisation) as supplier of Oncology and ARV/HIV products. Unique Latin American lab approved at the time.Development of ARV/HIV business in Nigeria.Approval of WHO (World Health Organisation) as supplier of ARV/HIV for Global Fund to African Programs. Unique Latin American lab approved at the time.

Responsible for the Export structure creation, development and managing of a generic argentine laboratory of US stockholders (Advent Fund), biggest local company of injectables (powders and lyophilised), syrups, pills, tablets, non sterile liquids (antiseptics) and a wide range of products of the following lines: Cardiology, Anaesthesia, General, Antibiotics, Immflamation and Pain, Vitamins and Oligoelements. Introduction of exports management methodology into the company and for supervising development activities on marketed drugs (regulatory affairs, commercialization).Main achievements:Exports structure Creation Initial research of Regional markets. Elaboration, presentation and implementation of International BusinessDevelopment of Five-year PlanElaboration, presentation and implementation of DMF Library Plan Research and Development on not traditional markets (Center and East of Europe, Asia and Africa)Business Cooperation agreements with laboratories of East Europe, South America (Brazil) and Asia. Fulfilment of Quantitative Objective of the first two years of the plan: 60% over the Objective each.Last Increment of turnover of the Sector in 8 months regarding the total of the previous year in 94,94%. Without contracts at the moment to assume the international management of business, at the end of my management, contracts for 11 million annual dollars of turnover have been signed.

Responsible for regional export development of an International Security printers (monetary titles, checks, fiduciaries stocks, etc) Public Gaming Administrators On Line Real Time Systems, and Documentation Printers. Regional Responsible for subsidiaries in Latin America (Brazil, Chile, Uruguay, Peru, Argentina).Main achievements:Project, implementation and managing of 4 new subsidiaries. Long term contract negotiation with local authorities.

Responsible for export and logistic of one of the biggest argentine food industry, grain, food and commodities exporters. Supply and commodities imports, including research and purchase negotiation. Holding Georgalos is composed with 5 companies (Georgalos, Aligeo, Poligraf, Celoprint y Geoservicios).Main achievements:Managing of export of 70 containers monthly sold. First commercial agreement under the Mercosur.Participating as a negotiator by the commodities export sector, of the construction of the Mercosur.

Projects, Distribution Agreements and PartnershipsTechnology Transfer for Plant Insulin - Bahrain - 2010/2011 Technology Transfer and construction of Plant biological - Kuwait 2013 Representation Contract Laboratory of Kedrion - Bangladesh Market Regional Representation Agreement - Hong Kong Pharma Distributors